Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Pliant Therapeutics Inc (PLRX)

Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors GlobeNewswire - Thu Dec 4, 6:30AM CST

One complete response and three partial responses observed  in heavily pretreated ICI-secondary refractory patients in high dose cohorts Deep and durable ongoing responses with median time on treatment...

PLRX : 1.2650 (-4.17%)
Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference GlobeNewswire - Mon Dec 1, 7:30AM CST

SOUTH SAN FRANCISCO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics,...

PLRX : 1.2650 (-4.17%)
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results GlobeNewswire - Thu Nov 6, 3:05PM CST

Oncology program advancing with data expected in the fourth quarter 2025 BEACON-IPF close out activities to be completed in the fourth quarter 2025 SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025...

PLRX : 1.2650 (-4.17%)
Pliant Therapeutics (PLRX) was downgraded to a Sell Rating at J.P. Morgan Tipranks - Wed Oct 15, 7:14AM CDT

Pliant Therapeutics received a Sell rating and price target from J.P. Morgan analyst Brian Cheng today. The company’s shares closed yesterday at $1.49.Elevate Your Investing Strategy: Take advantage...

PLRX : 1.2650 (-4.17%)
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results GlobeNewswire - Thu Aug 7, 3:05PM CDT

BEACON-IPF close out activities continue Previously announced workforce and operational realignment largely complete Phase 1 oncology trial on track to deliver additional data by the end of the...

PLRX : 1.2650 (-4.17%)
Pliant Therapeutics Provides Update on BEACON-IPF GlobeNewswire - Fri Jun 27, 3:05PM CDT

PLRX : 1.2650 (-4.17%)
Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference GlobeNewswire - Wed May 21, 3:03PM CDT

PLRX : 1.2650 (-4.17%)
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results GlobeNewswire - Thu May 8, 3:05PM CDT

PLRX : 1.2650 (-4.17%)
Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations GlobeNewswire - Thu May 1, 3:05PM CDT

PLRX : 1.2650 (-4.17%)
Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference GlobeNewswire - Mon Apr 7, 3:05PM CDT

PLRX : 1.2650 (-4.17%)

Barchart Exclusives

Visa’s Unusual Options Activity on Thursday Signals 3 Smart Profit Moves You Can Make Now Barchart - 34 minutes ago
Action on Visa stock was busy in Thursday's trading. Share volume was nearly double its 30-day average, and options volume was almost three times the monthly average. More importantly, its unusual options activity offers three ways for investors to profit. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot